연구동향 분석

Original Article : Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma

( Hyo Jeong Lee ) ( Hyo Jeong Kang ) ( Kang Mo Kim ) ( Eun Sil Yu ) Ki-Hun Kim ( Seung Mi Kim ) ( Tae Won Kim ) ( Ju Hyun Shim ) ( Young Suk Lim ) ( Han Chu Lee ) ( Young Hwa Chung ) ( Yung Sang Lee ) 2015년

논문상세정보
인용/피인용
' Original Article : Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • fibroblastgrowthfactor
  • hepatocellular carcinoma
  • immunohistochemistry
  • receptor
  • survival
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
686 0

0.0%

' Original Article : Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma' 의 참고문헌

  • Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis
    Gauglhofer C Hepatology 53 : 854 ~ 864 [2011]
  • The significance of fibroblast growth factor receptor 2 expression in differentiation of hepatocellular carcinoma
    Harimoto N Oncology 78 : 361 ~ 368 [2010]
  • The role of fibroblast growth factors and their receptors in prostate cancer
    Kwabi-Addo B Endocr Relat Cancer 11 : 709 ~ 724 [2004]
  • Targeting fgf19 inhibits tumor growth in colon cancer xenograft and fgf19transgenic hepatocellular carcinoma models
    Desnoyers LR Oncogene 27 : 85 ~ 97 [2008]
  • Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy : Comparative effectiveness of treatment modalities
    Ho CM Surgery 5 : 700 ~ 709 [2012]
  • Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase
    Kan M J Biol Chem 274 : 15947 ~ 15952 [1999]
  • Sorafenib in advanced hepatocellular carcinoma
    Llovet JM N Engl J Med 359 : 378 ~ 390 [2008]
  • Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kda phosphoprotein
    Kanai M J Biol Chem 272 : 6621 ~ 6628 [1997]
  • Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis
    Huang X Mol Carcinog 48 : 553 ~ 562 [2009]
  • Reduced expression of fibroblast growth factor receptor 2iiib in hepatocellular carcinoma induces a more aggressive growth
    Amann T Am J Pathol 176 : 1433 ~ 1442 [2010]
  • Overexpression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma
    Qiu WH World J Gastroenterol 11 : 5266 ~ 5272 [2005]
  • Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials
    Llovet JM Hepatology 29 : 62 ~ 67 [1999]
  • Molecular targeted therapies in hepatocellular carcinoma
    Llovet JM Hepatology 48 : 1312 ~ 1327 [2008]
  • Modern pathogenetic concepts of liver fibrosis suggest stellate cells and tgf-beta as major players and therapeutic targets
    Gressner AM J Cell Mol Med 10 : 76 ~ 99 [2006]
  • Metabolic regulator betaklotho interacts with fibroblast growth factor receptor 4(fgfr4)to induce apoptosis and inhibit tumor cell proliferation
    Luo Y J Biol Chem 285 : 30069 ~ 30078 [2010]
  • Liver fibrosis
    Bataller R J Clin Invest 115 : 209 ~ 218 [2005]
  • Interferon-alpha/beta and anti-fibroblast growth factor receptor 1 monoclonal antibody suppress hepatic cancer cells in vitro and in vivo
    Sasaki S PLoS One 6 : e19618 ~ [2011]
  • Hepatocellular carcinoma: Epidemiology, surveillance, and diagnosis
    Sherman M Semin Liver Dis 30 : 3 ~ 16 [2010]
  • Hepatocellular carcinoma
    Llovet JM The Lancet 362 : 1907 ~ 1917 [2003]
  • Fibroblast growth factor signalling : From development to cancer
    Turner N Nat Rev Cancer 10 : 116 ~ 129 [2010]
  • Fibroblast growth factor signaling in tumorigenesis
    Grose R Cytokine Growth Factor Rev 16 : 179 ~ 186 [2005]
  • Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alphafetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention
    Ho HK J Hepatol 50 : 118 ~ 127 [2009]
  • Fibroblast growth factor receptor 2(fgfr2) : Genomic sequence and variations
    Ingersoll RG Cytogenet Cell Genet 94 : 121 ~ 126 [2001]
  • Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
    Miura S BMC Cancer 12 : 56 ~ [2012]
  • Fgf signaling network in the gastrointestinal tract(review)
    Katoh M Int J Oncol 29 : 163 ~ 168 [2006]
  • Expression of transforming growth factor alpha/epidermal growth factor receptor, hepatocyte growth factor/c-met and acidic fibroblast growth factor/fibroblast growth factor receptors during hepatocarcinogenesis
    Hu Z Carcinogenesis 17 : 931 ~ 938 [1996]
  • Expression of fibroblast growth factor receptors flg and bek during hepatic ontogenesis and regeneration in the rat
    Hu Z Cell Growth Differ 6 : 1019 ~ 1025 [1995]
  • Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis
    Huang X Cancer Res 66 : 1481 ~ 1490 [2006]
  • Downregulation of microrna-214and overexpression of fgfr-1 contribute to hepatocellular carcinoma metastasis
    Wang J Biochem Biophys Res Commun 439 : 47 ~ 53 [2013]
  • Clinical features of hepatocellular carcinoma with extrahepatic metastases
    Natsuizaka M J Gastroenterol Hepatol 20 : 1781 ~ 1787 [2005]
  • Cancer genomics and genetics of fgfr2(review)
    Katoh M Int J Oncol 33 : 233 ~ 237 [2008]
  • Bek and flg, two receptors to members of the fgf family, are amplified in subsets of human breast cancers
    Adnane J Oncogene 6 : 659 ~ 663 [1991]
  • Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis c virus cirrhotic patients awaiting liver transplantation
    Mas VR Transplantation 84 : 1262 ~ 1271 [2007]
  • Adjuvant therapy options following curative treatment of hepatocellular carcinoma : A systematic review of randomized trials
    Zhong JH Eur J Surg Oncol 38 : 286 ~ 295 [2012]